155 related articles for article (PubMed ID: 34399391)
1. Identification and structure-activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li Q; Deng X; Jiang N; Meng L; Xing J; Jiang W; Xu Y
Eur J Med Chem; 2021 Dec; 225():113765. PubMed ID: 34399391
[TBL] [Abstract][Full Text] [Related]
2. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study.
Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G
Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the benzamide fragment targeting the S
Deng X; Wang N; Meng L; Zhou S; Huang J; Xing J; He L; Jiang W; Li Q
Bioorg Chem; 2020 Jan; 94():103366. PubMed ID: 31640932
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
5. ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.
Jain MR; Joharapurkar AA; Kshirsagar SG; Patel VJ; Bahekar RH; Patel HV; Jadav PA; Patel PR; Desai RC
Br J Pharmacol; 2017 Jul; 174(14):2346-2357. PubMed ID: 28452143
[TBL] [Abstract][Full Text] [Related]
6. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
Deng X; Han L; Zhou J; Zhang H; Li Q
Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY
Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.
Li Q; Han L; Zhang B; Zhou J; Zhang H
Org Biomol Chem; 2016 Oct; 14(40):9598-9611. PubMed ID: 27714283
[TBL] [Abstract][Full Text] [Related]
9. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
10. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes.
Wang Y; Tang X; Yi L
Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors.
Huang J; Deng X; Zhou S; Wang N; Qin Y; Meng L; Li G; Xiong Y; Fan Y; Guo L; Lan D; Xing J; Jiang W; Li Q
Bioorg Med Chem; 2019 Feb; 27(4):644-654. PubMed ID: 30642693
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes.
Cho TP; Long YF; Gang LZ; Yang W; Jun LH; Yuan SG; Hong FJ; Lin W; Liang GD; Lei Z; Jing LJ; Shen GA; Hong SG; Dan W; Ying F; Ke YP; Ying L; Jun F; Tai MX
Bioorg Med Chem Lett; 2010 Jun; 20(12):3565-8. PubMed ID: 20488702
[TBL] [Abstract][Full Text] [Related]
13. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes.
Wang J; Feng Y; Ji X; Deng G; Leng Y; Liu H
Bioorg Med Chem; 2013 Dec; 21(23):7418-29. PubMed ID: 24153396
[TBL] [Abstract][Full Text] [Related]
15. DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity.
Yeh KC; Yeh TK; Huang CY; Hu CB; Wang MH; Huang YW; Chou LH; Ho HH; Song JS; Hsu T; Jiaang WT; Chao YS; Chen CT
Life Sci; 2021 Aug; 278():119574. PubMed ID: 33961850
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.
Li S; Xu H; Cui S; Wu F; Zhang Y; Su M; Gong Y; Qiu S; Jiao Q; Qin C; Shan J; Zhang M; Wang J; Yin Q; Xu M; Liu X; Wang R; Zhu L; Li J; Xu Y; Jiang H; Zhao Z; Li J; Li H
J Med Chem; 2016 Jul; 59(14):6772-90. PubMed ID: 27396490
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
[TBL] [Abstract][Full Text] [Related]
18. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Pharmacol Rep; 2009; 61(5):899-908. PubMed ID: 19904014
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys.
Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ
Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760
[TBL] [Abstract][Full Text] [Related]
20. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors.
Deng X; Shen J; Zhu H; Xiao J; Sun R; Xie F; Lam C; Wang J; Qiao Y; Tavallaie MS; Hu Y; Du Y; Li J; Fu L; Jiang F
Bioorg Med Chem; 2018 Feb; 26(4):903-912. PubMed ID: 29373269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
